Search
Close this search box.
floating black insulin patch pump system, niia essential

PharmaSens successfully submits FDA approval application for Insulin Patch Pump System

Published: 17 January 2024

PharmaSens AG has achieved a significant step in its commitment to addressing unmet needs in diabetes management. The company recently submitted its application for FDA approval for the innovative ‘niia essential’ insulin patch pump system. This innovative device is the first of three patch pumps currently under development by PharmaSens.

Shore and PharmaSens

At Shore we’re proud to work with the team at PharmaSens and extremely pleased to hear of this next step in the product’s journey.

Our partnership began in 2021 focusing on providing mechanical engineering design expertise for the insulin filling aid component of ‘niia essential’.

insulin patch pump system with

Successful early involvement in the project paved the way for us to expand our collaboration and contribute to the entire niia essential development.

We have since gone on to deliver industrial design to enhance the appearance of all physical components, graphic design for all printed aspects (such as Instructions for Use and primary and secondary packaging), training initiatives, plus UI/UX design and implementation support for the insulin pump’s configuration app.

Working with the PharmaSens team, we’re simplifying diabetes management and making insulin pump therapy accessible to more people with diabetes.

Nicole Bernini, Head of Marketing at PharmaSens: “Working with Shore has been an absolute delight. Their professionalism and meticulous attention to detail have truly impressed me. It’s as if they possess a superpower, effortlessly simplifying complex tasks.

Our teamwork has been exceptionally strong, and I’ve thoroughly enjoyed being part of this outstanding experience. Kudos to the entire crew for making it truly remarkable!”

Scott Martin, Lead Designer at Shore, adds: “We love working with the PharmaSens team. It’s been a privilege to be able to deploy an entire spectrum of expertise at Shore within a single project. The result is a well-considered, and coherent design through all aspects of the system. It’s great to see the design taken to the next stage with the FDA approval submission”.

Could the next product milestone we discuss be yours?

Contact our Business Development Manager, Holly to explore how we can work with you.

Recent News

The image shows a person holding an injection trainer device with the brand name "Shore" clearly visible on it. The device is white with an orange cap and has a clear window showing its internal mechanism. The text on the device reads "Injection Trainer" and specifies "Does not contain needle or medication." The person's left hand is seen removing the transparent cap from the orange tip of the device, indicating the preparation for a simulated injection.

Shore granted US patent for autoinjector trainer design

Shore achieves Carbon Neutral status for 2024

Med-Tech Innovation Expo logo- 5-6 June 2024, NEC, Birmingham, UK

Med-Tech Innovation Expo 2024